Infectious Diseases Research
Research in the Division of Infectious Diseases is focused primarily on:
HIV/AIDS
The research in HIV/AIDS includes basic science, clinical research, and
epidemiology projects. Basic research on HIV is led by Dr. Donald Forthal and
focuses on understanding how antibodies interact with cells of the immune system
to inhibit HIV. This research is supported by the National Institutes of Health (NIH) and by the Universitywide
AIDS Research Program (UARP). His work in this area has resulted in
collaborations with faculty in the Departments of Pathology, and Microbiology
and Molecular Genetics, as well as national and international
collaborations.
HIV clinical research has been led by Drs. Jeremiah Tilles, Catherine Diamond,
and Steven Park with primary support through the California Cooperative
Treatment Group (a consortium of four institutions in California funded by the
UARP). Dr. Diamond is supported by the NIH to conduct research on the
epidemiology of HIV-related cancers.
Emerging Infectious Diseases
Arthropod-borne diseases, including their ecology, evolutionary biology, and
host interactions are a current area of strength within the Division. The
research of two faculty members, Drs. Guiyun Yan and Alan Barbour, is focused in this
area.
Dr. Barbour is the Principal Investigator of the Pacific Southwest
Regional Center for Excellence in Biodefense and Emerging Infectious Diseases (RCE).
This multicenter collaboration, funded by the NIH, establishes the Division of
Infectious Diseases as a leader in these critical areas of research. Other current faculty members involved in the RCE include Drs. Donald Forthal and Guiyun Yan. Dr. Yan, who joined the UC Irvine faculty in fall 2006 and has a primary
appointment in the Program in Public Health, researches the population biology of malaria vectors and malaria epidemiology.
Bioterrorism and Development of Vaccines and Diagnostics
As of July 1, 2006, the Division added two research faculty members Drs. Phil
Felgner and Huw Davies in the areas of proteomics, and of vaccine and diagnostic
reagent development. These faculty are funded by the NIH, industry, and private
foundations and have collaborations with the RCE.
Bacterial Pathogenesis
Pathogenesis of chlamydia infections is another area of research strength within
the Division. Dr. Ming Tans work in this area is funded by the NIH and the American
Heart Association and involves collaborations with faculty in other departments
at UC Irvine and outside of UCI.